Blossom Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,163
Closed -$248K 63
2023
Q3
$248K Buy
3,163
+17
+0.5% +$1.42K 0.79% 49
2023
Q2
$277K Buy
3,146
+405
+15% +$34.9K 1.01% 43
2023
Q1
$221K Buy
+2,741
New +$223K 0.9% 49
2022
Q2
Sell
-2,126
Closed -$236K 47
2022
Q1
$236K Buy
2,126
+130
+7% +$13.7K 1.06% 42
2021
Q4
$206K Buy
+1,996
New +$231K 1.01% 43

Other funds holding MDT

Blossom Wealth Management's MDT Position: Q4 2023 in Review

Blossom Wealth Management sold out of Medtronic (MDT) in Q4 2023, closing a stake of 3,163 shares — an estimated $248K sold.

Blossom Wealth Management first reported a position in MDT in Q4 2021 and held it in 5 quarters. The position peaked at $277K in Q2 2023. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Blossom Wealth Management reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Blossom Wealth Management sold 3,163 Medtronic shares in Q4 2023, an estimated $248K.
  • Blossom Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 5 quarters.
  • Blossom Wealth Management's Medtronic position peaked at $277K in Q2 2023.
  • 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Blossom Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.